KRM22 (KRM): Corp Interims to June 2020 | Shield Therapeutics (STX): Corp Interims in line, awaiting US partner
16 Sep 2020
Morning Note – 16 September 2020
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note – 16 September 2020
Shield Therapeutics Plc (STX:LON), 1.4 | KRM22 Plc (KRM:LON), 27.5
- Published:
16 Sep 2020 -
Author:
Andrew Darley | Mark Brewer | Cavendish Research -
Pages:
4
KRM22 (KRM): Corp Interims to June 2020 | Shield Therapeutics (STX): Corp Interims in line, awaiting US partner